{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:10:59Z","timestamp":1789661459713,"version":"4.0.1"},"reference-count":45,"publisher":"Centers for Disease Control MMWR Office","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Surveill. Summ."],"DOI":"10.15585\/mmwr.ss6905a1","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T17:10:55Z","timestamp":1599153055000},"page":"1-18","source":"Crossref","is-referenced-by-count":22,"title":["Evaluation of CDC\u2019s Hemophilia Surveillance Program \u2014 Universal Data Collection (1998\u20132011) and Community Counts (2011\u20132019), United States"],"prefix":"10.15585","volume":"69","author":[{"given":"Laura A.","family":"Schieve","sequence":"first","affiliation":[{"name":"Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa R.","family":"Byams","sequence":"additional","affiliation":[{"name":"Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi","family":"Dupervil","sequence":"additional","affiliation":[{"name":"Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith A.","family":"Oakley","sequence":"additional","affiliation":[{"name":"Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie H.","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Soucie","sequence":"additional","affiliation":[{"name":"Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karon","family":"Abe","sequence":"additional","affiliation":[{"name":"Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Bean","sequence":"additional","affiliation":[{"name":"Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Craig","family":"Hooper","sequence":"additional","affiliation":[{"name":"Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R1","doi-asserted-by":"publisher","first-page":"E2382","DOI":"10.1002\/humu.22247","article-title":"The CDC Hemophilia A Mutation Project (CHAMP) mutation list: a new online resource.","volume":"34","author":"Payne","year":"2013","journal-title":"Hum Mutat"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/mgg3.30","article-title":"The CDC Hemophilia B Mutation Project mutation list: a new online resource.","volume":"1","author":"Li","year":"2013","journal-title":"Mol Genet Genomic Med"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I","article-title":"Occurrence of hemophilia in the United States.","volume":"59","author":"Soucie","year":"1998","journal-title":"Am J Hematol"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/hae.13734","article-title":"Population-based surveillance of haemophilia and patient outcomes in Indiana using multiple data sources.","volume":"25","author":"Okolo","year":"2019","journal-title":"Haemophilia"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R5","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1182\/blood-2015-10-675140","article-title":"Men with severe hemophilia in the United States: birth cohort analysis of a large national database.","volume":"127","author":"Mazepa","year":"2016","journal-title":"Blood"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R6","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.thromres.2013.10.020","article-title":"The history of haemophilia\u2014a short review.","volume":"134","author":"Schramm","year":"2014","journal-title":"Thromb Res"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1538-7836.2006.01776.x","article-title":"Life expectancy in hemophilia outcome.","volume":"4","author":"Mejia-Carvajal","year":"2006","journal-title":"J Thromb Haemost"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1750-1172-7-24","article-title":"Past, present and future of hemophilia: a narrative review.","volume":"7","author":"Franchini","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R9","first-page":"61","article-title":"Hemophilia: an amazing 35-year journey from the depths of HIV to the threshold of cure.","volume":"121","author":"White","year":"2010","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R10","first-page":"1152","article-title":"Blood safety monitoring among persons with bleeding disorders\u2014United States, May 1998\u2013June 2002.","volume":"51","author":"CDC","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R11","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.2105\/AJPH.2004.051318","article-title":"A model for a regional system of care to promote the health and well-being of people with rare chronic genetic disorders.","volume":"95","author":"Baker","year":"2005","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R12","unstructured":"National Hemophilia Foundation, Medical and Scientific Advisory Council (MASAC). Standards and criteria for the care of persons with congenital bleeding disorders. New York, NY: National Hemophilia Foundation; 2002.  https:\/\/www.hemophilia.org\/sites\/default\/files\/document\/files\/masac132.pdf"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/hae.13008","article-title":"NHF-McMaster guideline on care models for haemophilia management.","volume":"22","author":"Pai","year":"2016","journal-title":"Haemophilia"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R14","first-page":"437","article-title":"Mortality among males with hemophilia: relations with source of medical care.","volume":"96","author":"Soucie","year":"2000","journal-title":"Blood"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1182\/blood-2005-09-3879","article-title":"Bleeding in carriers of hemophilia.","volume":"108","author":"Plug","year":"2006","journal-title":"Blood"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R16","doi-asserted-by":"publisher","first-page":"E137","DOI":"10.1002\/ajh.25076","article-title":"Community Counts: evolution of a national surveillance system for bleeding disorders.","volume":"93","author":"Manco-Johnson","year":"2018","journal-title":"Am J Hematol"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1046\/j.1365-2516.2003.00780.x","article-title":"The epidemiology of inhibitors in haemophilia A: a systematic review.","volume":"9","author":"Wight","year":"2003","journal-title":"Haemophilia"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R18","article-title":"Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group.","volume":"50","author":"German","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R19","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1537-2995.2004.04029.x","article-title":"Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range-of-motion limitation.","volume":"44","author":"Soucie","year":"2004","journal-title":"Transfusion"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R20","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1537-2995.2012.03907.x","article-title":"Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening.","volume":"53","author":"Soucie","year":"2013","journal-title":"Transfusion"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/hae.12073","article-title":"Prevalence of clinical hip abnormalities in haemophilia A and B: an analysis of the UDC database.","volume":"19","author":"Kelly","year":"2013","journal-title":"Haemophilia"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R22","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1182\/blood-2003-05-1457","article-title":"Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors.","volume":"103","author":"Soucie","year":"2004","journal-title":"Blood"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1365-2516.2010.02400.x","article-title":"The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia A.","volume":"17","author":"Soucie","year":"2011","journal-title":"Haemophilia"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1365-2516.2008.01662.x","article-title":"Septic arthritis in males with haemophilia.","volume":"14","author":"Ashrani","year":"2008","journal-title":"Haemophilia"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/bjh.12267","article-title":"The effect of secondary prophylaxis versus episodic treatment on the range of motion of target joints in patients with haemophilia.","volume":"161","author":"Gupta","year":"2013","journal-title":"Br J Haematol"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R26","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/hae.13511","article-title":"Risk factors associated with invasive orthopaedic interventions in males with haemophilia enrolled in the Universal Data Collection program from 2000 to 2010.","volume":"24","author":"Tobase","year":"2018","journal-title":"Haemophilia"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R27","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1182\/blood-2016-02-683169","article-title":"Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project.","volume":"129","author":"Manco-Johnson","year":"2017","journal-title":"Blood"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R28","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/hae.13317","article-title":"Prophylaxis use among males with haemophilia B in the United States.","volume":"23","author":"Ullman","year":"2017","journal-title":"Haemophilia"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/hae.13081","article-title":"Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System.","volume":"23","author":"Kulkarni","year":"2017","journal-title":"Haemophilia"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R30","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ajh.23957","article-title":"Impact of inhibitors on hemophilia A mortality in the United States.","volume":"90","author":"Walsh","year":"2015","journal-title":"Am J Hematol"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/hae.13435","article-title":"Effects of pre-analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels.","volume":"24","author":"Boylan","year":"2018","journal-title":"Haemophilia"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R32","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1111\/jth.13438","article-title":"Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.","volume":"14","author":"Boylan","year":"2016","journal-title":"J Thromb Haemost"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/jth.12768","article-title":"Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.","volume":"13","author":"Boylan","year":"2015","journal-title":"J Thromb Haemost"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R34","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1111\/jth.13795","article-title":"Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors.","volume":"15","author":"Miller","year":"2017","journal-title":"J Thromb Haemost"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R35","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/jth.12259","article-title":"Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the U.S. Hemophilia Inhibitor Research Study.","volume":"11","author":"Miller","year":"2013","journal-title":"J Thromb Haemost"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R36","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/j.1538-7836.2012.04705.x","article-title":"Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance.","volume":"10","author":"Miller","year":"2012","journal-title":"J Thromb Haemost"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R37","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1182\/bloodadvances.2018019323","article-title":"HLA-DRB1-factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia: a case-control study.","volume":"2","author":"Kempton","year":"2018","journal-title":"Blood Adv"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R38","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1111\/j.1538-7836.2010.04013.x","article-title":"In non-severe hemophilia A the risk of inhibitor after intensive factor treatment is greater in older patients: a case-control study.","volume":"8","author":"Kempton","year":"2010","journal-title":"J Thromb Haemost"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/hae.12302","article-title":"A study of prospective surveillance for inhibitors among persons with haemophilia in the United States.","volume":"20","author":"Soucie","year":"2014","journal-title":"Haemophilia"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1365-2516.2011.02700.x","article-title":"F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race\/ethnicity.","volume":"18","author":"Miller","year":"2012","journal-title":"Haemophilia"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R41","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/ajh.23645","article-title":"Mutation analysis of a cohort of US patients with hemophilia B.","volume":"89","author":"Li","year":"2014","journal-title":"Am J Hematol"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R42","unstructured":"National Hemophilia Foundation, Medical and Scientific Advisory Council (MASAC). MASAC recommendations on standardized testing and surveillance for inhibitors in patients with hemophilia A and B. MASAC document no. 236; October 2015. https:\/\/www.hemophilia.org\/Researchers-Healthcare-Providers\/Medical-and-Scientific-Advisory-Council-MASAC\/MASAC-Recommendations\/MASAC-Recommendations-on-Standardized-Testing-and-Surveillance-for-Inhibitors-in-Patients-with-Hemophilia-A-and-B"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R43","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1365-2516.2010.02399.x","article-title":"Range of motion measurements: reference values and a database for comparison studies.","volume":"17","author":"Soucie","year":"2011","journal-title":"Haemophilia"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R44","doi-asserted-by":"publisher","first-page":"S324","DOI":"10.1016\/j.amepre.2011.09.021","article-title":"Knowledge and therapeutic gaps: a public health problem in the rare coagulation disorders population.","volume":"41","author":"Shapiro","year":"2011","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss6905a1-202009031316-R45","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(08)60872-7","article-title":"Why rare diseases are an important medical and social issue.","volume":"371","author":"Schieppati","year":"2008","journal-title":"Lancet"}],"container-title":["MMWR. Surveillance Summaries"],"original-title":[],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T17:17:15Z","timestamp":1599153435000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/69\/ss\/ss6905a1.htm?s_cid=ss6905a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,9,4]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.ss6905a1","relation":{},"ISSN":["1546-0738","1545-8636"],"issn-type":[{"value":"1546-0738","type":"print"},{"value":"1545-8636","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9,4]]},"published":{"date-parts":[[2020,9,4]]}}}